SEC Form 4 · accession 0001209191-16-129418
Evofem Biosciences, Inc. · EVFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martha J Demski
Director
Period of report
Jun 21, 2016
Accepted (ET)
Jun 23, 2016 · 6:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618835
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 21, 2016 | M | 16,393 | $1.13 | A | 16,393 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.13 | Jun 21, 2016 | A | 12,450 | A | — | Jun 21, 2026 | Common Stock | 12,450 | 12,450 | D |
| Stock Option (Right to Buy) | $1.13 | Jun 21, 2016 | A | 16,393 | A | Jun 21, 2016 | Jun 21, 2026 | Common Stock | 16,393 | 16,393 | D |
| Stock Option (Right to Buy) | $1.13 | Jun 21, 2016 | M | 16,393 | D | Jun 21, 2016 | Jun 21, 2026 | Common Stock | 16,393 | 0 | D |
| Stock Option (Right to Buy)F2 | $1.13 | Jun 21, 2016 | A | 24,590 | A | — | Jun 21, 2026 | Common Stock | 24,590 | 24,590 | D |
Explanation of responses
- F1Option shares vest on June 21, 2017.
- F2(i) One third of the option shares vests on June 30, 2016, (ii) one third of the option shares vests on September 30, 2016 and (iii) the remaining one third of the option shares vests on December 31, 2016.